Navigation Links
Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer
Date:12/2/2009

BIRMINGHAM, Ala., Dec. 2 /PRNewswire/ -- Adults are more likely to lose their vision than be diagnosed with cancer. For adults 65 and over, the odds of losing vision are one in three, whereas the odds of a man developing prostate cancer are one in six and odds of a woman developing breast cancer are one in nine. Vision loss threatens the overall health of aging adults by increasing the risk of injuries, depression and inability to complete daily tasks.

Vision loss in adults is often attributed to age-related macular degeneration (AMD), a breakdown of the macula that destroys sharp, central vision. Damage to the macula causes blurriness and distortion of vision, which can affect the ability to see fine details clearly. AMD is the leading cause of blindness in American adults and affects millions of aging adults worldwide.

Though there is currently no cure for AMD, sufferers and aging adults can prevent the development or progression of the disease with proper nutrition. A study conducted at the Callahan Eye Foundation Hospital of Birmingham, Alabama revealed that AMD sufferers taking a specific eye vitamin supplement, Macular Health, showed both short-term and long-term improvement in visual acuity by 16 and 17 percent. Researchers attribute the improvement to Macular Health's specific dosage of lutein, zeaxanthin and bilberry, and the administration of specific carotenoids, vitamins and minerals.

As quoted in Ophthalmology Times, the creator of Macular Health, Dr. John O. Mason, III said, "This is the first time in my career that I have actually seen patients with dry AMD who have had improvements in vision and in the MERGs as a result of taking carotenoids, vitamin and mineral supplements."

Mason, a researcher and retina specialist, created Macular Health in 2003 to help his patients who were losing their vision to AMD. He based the Macular Health formula on the National Eye Institute's (N
'/>"/>

SOURCE Macular Health
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
2. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
3. Gene Therapy Provides Vision to People who Were Nearly Blind
4. Gene Therapy Improves Vision in Patients with Congenital Retinal Disease
5. Strykers Biotech Division Receives FDA Warning Letter
6. Menicon Undertakes With the Novovision Clinic a Paediatric Myopia Control Clinical Trial
7. Vision Problems Affect How Children Learn Math Skills
8. TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration
9. Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss
10. Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
11. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... -- Semler Scientific, Inc. (Nasdaq: SMLR ), a company ... and physician groups, today reported financial results for the ... "In the second quarter of 2015, Semler reported continued ... quarter over quarter revenue growth of 8%, and quarter ... units of 18%," said Doug Murphy-Chutorian, M.D., chief executive ...
(Date:7/31/2015)... According to a new market research report ... Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air Displacement Plethysmography ... to 2019", published by MarketsandMarkets, the global Body Composition ... is estimated to grow to $1,425.7 Million by 2019, ... 2019. Browse 41 market data Tables ...
(Date:7/30/2015)... International Inc. (NYSE: MTD ) today announced second ... , Sales in local currency increased 3% ... sales decreased 4% as currency reduced sales growth by ... diluted share as reported (EPS) were $2.73, compared with ... , an increase of 9% over the prior-year ...
Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14
... Omthera Pharmaceuticals, Inc., a privately-held emerging specialty ... and Chief Executive Officer, will present at the ... InterContinental Boston, in Boston, Massachusetts, on Wednesday, June ... About Omthera Pharmaceuticals, Inc.Founded in 2008, Omthera ...
... Alere Inc. (NYSE: ALR ) (the "Company") ... each of its consent solicitations commenced on May 31, ... the "Proposed Modifications") governing its 9.0% Senior Subordinated Notes ... due 2018 (the "8.625% Notes") and 7.875% Senior Notes ...
Cached Medicine Technology:
(Date:7/31/2015)... CA (PRWEB) , ... July 31, 2015 , ... ... by High Times magazine. What are the STASH awards? The Significant Technological ... made by the cannabis-cultivation community as well as tried-and-true products that have stood ...
(Date:7/31/2015)... New York (PRWEB) , ... July 31, 2015 , ... ... strut their stuff, Super-Sod debuted their new type of sod called Leisure Time(TM) ... trademark application in process. , To commemorate introduction of this new type of sod, ...
(Date:7/31/2015)... ... August 01, 2015 , ... Super Bowl 50 will emanate from Levi’s ... biggest day each year is the Super Bowl. In the two weeks that separate the ... the host venue. The 2016 Super Bowl game will mark the 50th time it has ...
(Date:7/31/2015)... ... 2015 , ... Precision Aesthetics is New York’s only Thermage skin tightening pinnacle ... provider of Exilis non-surgical fat reduction in New York. Due to its unparalleled ... International clientele. Many patients travel to New York to get their non-surgical skin ...
(Date:7/31/2015)... ... July 31, 2015 , ... Last week, the ... The store can be accessed by visiting http://www.curemeso.org/store . , “Our new ... The best part: whenever a product is purchased, the Meso Foundation receives a ...
Breaking Medicine News(10 mins):Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3
... (July 13, 2010) Pitt County Memorial ... study demonstrating that universal surveillance for methicillin-resistant ... (HAIs) related to devices. Infection rates decreased ... percent for central line-associated bacteremias (CLA-BSI); and ...
... HealthDay Reporter , TUESDAY, July 13 (HealthDay News) -- ... on the best way to use two classes of hormone ... of breast tumor. After a systematic review of medical ... inhibitor -- a drug that reduces the amount of estrogen ...
... BOSTON (July 13, 2010) With current public health ... contamination, innovations that better predict disease outbreaks have vast ... online in advance of print on July 6 in ... describe their vision for the future of disease surveillance, ...
... HealthDay Reporter , MONDAY, July 12 (HealthDay News) ... to open blocked arteries are getting proven treatments in U.S. ... the results of a large-scale study. Data on more ... from January 2007 through June 2009 also showed that the ...
... Stockholm, Sweden: Men who enter adult life obese face a life-long ... In a study presented today (Tuesday) at the International ... conscripts starting at the age of 20 until up to the ... obese man was twice as likely to die as a man ...
... of the Society for the Study of Ingestive Behavior (SSIB), ... and drinking behavior, finds that that feelings of hunger have ... and taste of food in overweight than healthy weight individuals. ... overweight participants and found that the overweight participants had greater ...
Cached Medicine News:Health News:Study shows universal surveillance for MRSA significantly decreased HAIs at PCMH 2Health News:Experts Issue New Guidelines on Breast Cancer Drugs 2Health News:Experts Issue New Guidelines on Breast Cancer Drugs 3Health News:Researchers envision better disease surveillance to improve public health 2Health News:Heart Attack Care Is Getting Better, Report Finds 2Health News:Heart Attack Care Is Getting Better, Report Finds 3Health News:Study finds lifelong doubling in death risk for men who are obese at age 20 years 2
... confirmed Atriums superior biocompatibility and strength ... hernia repair. These same studies indicate ... hernia mesh can result in a ... when Atrium first introduced thin wall ...
... Repair Company, we recognize that there are ... tissue in-growth between the prosthesis and the ... Like all the products in Bards complete ... clinically proven, versatile repair.,The Reconix Patch is ...
... In applications such as laparoscopic ... reconstruction, surgeons require a surgical biomaterial ... incorporation.,GORE MYCROMESH Biomaterial provides the answer ... soft tissue reconstructions. Made from strong, ...
... CompanySM is pleased to announce the latest ... Composix E/X mesh.,When Bard Composix mesh was ... ventral hernia repair prosthesis that combined two ... ePTFE, in one product. Bard Composix E/X ...
Medicine Products: